{{Rsnum
|rsid=2660917
|Chromosome=18
|position=70960842
|Orientation=plus
|GMAF=0.2126
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 5.4 | 39.3 | 55.4
| HCB | 1.5 | 16.2 | 82.4
| JPT | 1.8 | 6.2 | 92.0
| YRI | 9.0 | 42.1 | 49.0
| ASW | 10.5 | 43.9 | 45.6
| CHB | 1.5 | 16.2 | 82.4
| CHD | 0.9 | 19.4 | 79.6
| GIH | 17.8 | 35.6 | 46.5
| LWK | 12.8 | 35.8 | 51.4
| MEX | 1.7 | 32.8 | 65.5
| MKK | 14.1 | 46.8 | 39.1
| TSI | 7.8 | 37.3 | 54.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19084217
|Trait=Serum markers of iron status
|Title=Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels
|RiskAllele=
|Pval=0.000008
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs2660917
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19084217; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. (Initial Sample Size: 459 twin pairs; Replication Sample Size: NR); (Region: 18q22.2; Reported Gene(s): Intergenic; Risk Allele: rs2660917-?); (p-value= 0.000008).This variant is associated with Serum markers of iron status.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740114
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2660917
|overall_frequency_n=27
|overall_frequency_d=114
|overall_frequency=0.236842
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=23
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}